When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HEB - Hemispherx Bio up 24% premarket on encouraging Ampligen data
Hemispherx BioPharma Inc.
Thinly traded nano cap Hemispherx Biopharma (NYSEMKT:HEB) is up 24% premarket on average volume in reaction to positive results from a Phase 1 study evaluating a combination therapy that included Ampligen (rintatolimod) in patients with recurrent ovarian cancer.
More news on: Hemispherx Biopharma, Inc., Healthcare stocks news, Stocks on the move,